Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lipocine Inc (NASDAQ:LPCN)

3.73
Delayed Data
As of Dec 09
 +0.14 / +3.90%
Today’s Change
2.51
Today|||52-Week Range
13.38
-71.15%
Year-to-Date
No recent news for Lipocine Inc.

Today’s Trading

Previous close3.59
Today’s open3.63
Day’s range3.60 - 3.78
Volume165,540
Average volume (3 months)423,457
Market cap$68.1M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+30.63%
Earnings growth (this year)-8.54%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.62

Competitors

 Today’s
change
Today’s
% change
NNVCNanoViricides Inc+0.02+1.72%
CATBCatabasis Pharmaceut...+0.09+2.56%
EPIXESSA Pharma Inc0.000.00%
AFMDAffimed NV-0.05-2.44%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$0.00
Annual profit (last year)-$18.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Mahesh V. Patel
CFO, Principal Accounting Officer &
EVP
Morgan R. Brown
Corporate headquarters
Salt Lake City, Utah

Forecasts


Search for Jobs